Metraipolis › archive › dc_8db9679d2f38

Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer — Europe PMC PMID:42095302

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42095302
DOI
10.1002/iid3.70437
License (as archived)
solo-consultazione
Archived
2026-11-02T21:33:18.174Z
SHA-256 of the archived text
2633662b5059af37f2f7e396d8fa844f046d97c3d93b334a92b6d33e945cc8d3
Stable URL of this page
https://metraipolis.com/documento/dc_8db9679d2f38

How to cite

Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer — Europe PMC PMID:42095302 — Europe PMC (en), https://europepmc.org/article/MED/42095302 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8db9679d2f38 (Metraipolis archive dc_8db9679d2f38, sha256 2633662b5059af37f2f7e396d8fa844f046d97c3d93b334a92b6d33e945cc8d3)
BibTeX
@misc{dc8db9679d2f38,
  title = {Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer — Europe PMC PMID:42095302},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42095302},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8db9679d2f38; sha256 2633662b5059af37f2f7e396d8fa844f046d97c3d93b334a92b6d33e945cc8d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42095302. Agents can read the archived copy with the MCP tool read_document.